Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT04624633
Title AU2 In Relapsed and Untreated CLL
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Jennifer R. Brown, MD, PhD
Indications

chronic lymphocytic leukemia/small lymphocytic lymphoma

chronic lymphocytic leukemia

Therapies

Acalabrutinib + Ublituximab + Umbralisib

Age Groups: adult | senior
Covered Countries USA


No variant requirements are available.